Curapulse Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Curapulse Co., Ltd. - overview
Established
2025
Location
Busan, -, South Korea
Primary Industry
Medical Devices & Equipment
About
Based in Busan, South Korea, Curapulse Co. , Ltd. specializes in innovative medical and wellness solutions, harnessing technologies like ultrasound and electrical stimulation to enhance cognitive functions and skincare. Curapulse Co.
, Ltd. was founded in 2025 in Busan, South Korea, by Nam-kyu Cho, who serves as the CEO. The company focuses on advanced medical technologies and wellness solutions, positioning itself as a key player in the market. It has completed two funding deals, with the most recent transaction occurring on May 7, 2026, raising an undisclosed amount of pre-series A funding led by new investor G&P Investment.
Curapulse Co. , Ltd. specializes in advanced medical and wellness solutions that leverage innovative technologies such as ultrasound, electrical stimulation, and LED. Their core product offerings include neuromodulation platforms like SB BrainStim™ and BrainSync™, aimed at improving cognitive functions such as focus, stress reduction, sleep enhancement, and memory support.
Additionally, in the skincare sector, Curapulse provides rejuvenation solutions through proprietary technologies like DualTetra WaveSync™, DualPoration™, and IntraSonix™, which work by combining ultrasound, pulse wave, and phototherapy to improve skin elasticity and combat aging. The company's products are marketed globally, targeting various consumer segments, including healthcare providers, wellness clinics, and individual consumers seeking both home and professional skincare and cognitive enhancement solutions. Curapulse operates on a business model characterized by both direct-to-consumer and B2B transactions, enabling the company to reach a diverse clientele. Revenue streams are generated through the sale of its innovative devices, including flagship products like SB BrainStim™ and DualTetra WaveSync™.
The company partners with wellness clinics and healthcare providers, facilitating bulk purchases and potentially establishing subscription models for ongoing support and product updates. Additionally, Curapulse offers OEM and ODM services, allowing other brands to leverage their proprietary technologies in customized solutions. By fostering partnerships and direct sales, Curapulse effectively capitalizes on various distribution channels, ensuring broad market penetration and consumer engagement across multiple geographical regions.
Current Investors
New Paradigm Investment, G&P Investment
Primary Industry
Medical Devices & Equipment
Sub Industries
Beauty & Hygiene, Medical Devices & Equipment
Website
www.cura-pulse.com/
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.